Cannabis Policy
Thailand Moves to Decriminalize Cannabis
Thailand is on its way to becoming the first country in Asia to decriminalize cannabis.
Delta-8 THC Consumers Consider it “Delta-9’s Nicer Sibling,” Survey Finds
Delta-8 THC products provide all the benefits of delta-9 THC but with fewer adverse effects, according to consumers.
Price of Cannabis Continues to Fall in Canada After Legalization
Researchers from the University of Waterloo, Ontario, report that the mean price of dried flower from legal sources fell in 2019 and then again in 2020.
Cannabis “Poisonings” in Children Increased Ninefold After Edibles Were Legalized in Canada, Study Finds
After commercial edibles became legally available in 2019, cannabis-related exposures were seen to be responsible for nearly 10 percent of all ED visits for poisonings in Ontario.
Canadian Patients Now Have Better Access to Psychedelic-assisted Therapy, Following a Federal Amendment
Doctors in Canada can now request psychedelic-assisted therapies for their patients through a new program, following an amendment to Health Canada’s Special Access Program (SAP).
The Top 10 Cannabis Stories of 2021
The year posed many challenges, but cannabis businesses, research centers, and reform groups still managed to make impressive headway. Analytical Cannabis looks back on the stories and issues that dominated the cannabis industry in 2021.
The Challenges of Standardizing and Regulating Hemp Testing
Kimberly Ross of Peak Compliance Labs outlines the many obstacles hemp faces before it becomes fully regulated in the US.
UK Regulator Issues New Advice on THC Levels in CBD Products
The recommendations have largely been welcomed by many in the UK’s CBD industry.
Pfizer Enters Medical Cannabis Sector With $6 Billion Acquisition
Pfizer is set to acquire Arena Pharmaceuticals, a San Diego-based company currently developing a cannabinoid therapeutic called Olorinab.
